Found: 27
Select item for more details and to access through your institution.
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non-small-cell Lung Cancer Developing After Surgery.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective Analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
- Published in:
- Respirology, 2024, v. 29, n. 9, p. 815, doi. 10.1111/resp.14724
- By:
- Publication type:
- Article
Phase II study of amrubicin at a dose of 45mg/m² in patients with previously treated small-cell lung cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 10, p. 941, doi. 10.1093/jjco/hyv107
- By:
- Publication type:
- Article
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30676-y
- By:
- Publication type:
- Article
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 4, p. 676, doi. 10.1007/s10147-021-02113-5
- By:
- Publication type:
- Article
Anaphylaxis to three humanized antibodies for severe asthma: a case study.
- Published in:
- Allergy, Asthma & Clinical Immunology, 2020, v. 16, n. 1, p. 1, doi. 10.1186/s13223-020-00446-w
- By:
- Publication type:
- Article
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1170, doi. 10.3390/cancers15041170
- By:
- Publication type:
- Article
Usefulness of Computed Tomography for Evaluating the Effects of Bronchial Thermoplasty in Japanese Patients with Severe Asthma.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 325, doi. 10.2147/JAA.S452865
- By:
- Publication type:
- Article
The genomic and epigenomic landscape in thymic carcinoma.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 11, p. 1084, doi. 10.1093/carcin/bgx094
- By:
- Publication type:
- Article
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 12, p. 1089, doi. 10.1111/1759-7714.14853
- By:
- Publication type:
- Article
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 5, p. 442, doi. 10.1111/1759-7714.14761
- By:
- Publication type:
- Article
Dramatic, significant metabolic response to a one‐time pembrolizumab treatment following a relapse of pre‐existing organizing pneumonia in a patient with advanced non‐small cell lung cancer: A case report.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 22, p. 3076, doi. 10.1111/1759-7714.14185
- By:
- Publication type:
- Article
Zinc‐finger E‐box‐binding homeobox 1 (ZEB1) plays a crucial role in the maintenance of lung cancer stem cells resistant to gefitinib.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 10, p. 1536, doi. 10.1111/1759-7714.13937
- By:
- Publication type:
- Article
Impact of the generation of EGFR‐TKIs administered as prior therapy on the efficacy of osimertinib in patients with non‐small cell lung cancer harboring EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 3, p. 329, doi. 10.1111/1759-7714.13742
- By:
- Publication type:
- Article
Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 1, p. 140, doi. 10.1111/1759-7714.13255
- By:
- Publication type:
- Article
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non‐small‐Cell Lung Cancer in Patients Aged 75 Years and Older.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1042, doi. 10.1002/cpt.3339
- By:
- Publication type:
- Article
Severe mediastinitis over a month after endobronchial ultrasound-guided transbronchial needle aspiration.
- Published in:
- Respirology Case Reports, 2019, v. 7, n. 5, p. 1, doi. 10.1002/rcr2.426
- By:
- Publication type:
- Article
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 423, doi. 10.1007/s11523-024-01048-x
- By:
- Publication type:
- Article
A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10133-1
- By:
- Publication type:
- Article
Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy.
- Published in:
- Oncology Letters, 2018, v. 15, n. 1, p. 747, doi. 10.3892/ol.2017.7354
- By:
- Publication type:
- Article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-508
- By:
- Publication type:
- Article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 508, doi. 10.1186/1471-2407-14-508
- By:
- Publication type:
- Article
Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article